TEKMIRA PHARMACEUTICALS CORP's ticker is TKMR and the CUSIP is 87911B209. A total of 48 filers reported holding TEKMIRA PHARMACEUTICALS CORP in Q4 2014. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $298,000 | – | 14,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 16,013,540 | $279,596,000 | 15.57% |
| RA Capital Management | 2,714,800 | $47,400,000 | 4.71% |
| Alpha Wave Global, LP | 2,221,000 | $38,779,000 | 1.90% |
| Redmile Group, LLC | 700,000 | $12,222,000 | 1.10% |
| HealthCor Management, L.P. | 718,800 | $12,550,000 | 0.60% |
| Monashee Investment Management LLC | 55,000 | $960,000 | 0.60% |
| SPHERA FUNDS MANAGEMENT LTD. | 298,486 | $5,212,000 | 0.54% |
| Telemetry Investments, L.L.C. | 48,000 | $838,000 | 0.46% |
| Anson Funds Management LP | 25,000 | $437,000 | 0.39% |
| Blue Ridge Capital, L.L.C. | 1,700,000 | $29,682,000 | 0.34% |